| Record ID | marc_loc_2016/BooksAll.2016.part30.utf8:230183151:930 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part30.utf8:230183151:930?format=raw |
LEADER: 00930cam a22002774a 4500
001 2003278477
003 DLC
005 20031112071401.0
008 031110s2000 ohua r 000 0 eng
010 $a 2003278477
040 $aDLC$cDLC
042 $apcc
043 $an-us---
050 00 $aHD9666.5$b.P43 2000
245 00 $aPharmaceutical chemicals /$cproject director, Mary F. Welch ; research analyst, Esther K. Kalevsky ; corporate researcher, Diana E. Kole.
260 $aCleveland :$bFreedonia Group,$cc2000.
300 $axii leaves, 297 p. :$bill. ;$c29 cm.
440 0 $aPrivate companies report ;$v1332
500 $a"September 2000."
650 0 $aPharmaceutical industry$zUnited States.
650 0 $aPharmaceutical industry$zUnited States$vDirectories.
650 0 $aMarket surveys$zUnited States.
700 1 $aWelch, Mary F.
700 1 $aPalevsky, Esther K.
700 1 $aKole, Diana E.
710 2 $aFreedonia Group.